242 related articles for article (PubMed ID: 16484658)
1. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.
Preusser M; Ströbel T; Gelpi E; Eiler M; Broessner G; Schmutzhard E; Budka H
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):413-6. PubMed ID: 16484658
[TBL] [Abstract][Full Text] [Related]
2. Dura mater is a potential source of Aβ seeds.
Kovacs GG; Lutz MI; Ricken G; Ströbel T; Höftberger R; Preusser M; Regelsberger G; Hönigschnabl S; Reiner A; Fischer P; Budka H; Hainfellner JA
Acta Neuropathol; 2016 Jun; 131(6):911-23. PubMed ID: 27016065
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting.
Frontzek K; Lutz MI; Aguzzi A; Kovacs GG; Budka H
Swiss Med Wkly; 2016; 146():w14287. PubMed ID: 26812492
[TBL] [Abstract][Full Text] [Related]
4. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.
Cali I; Cohen ML; Haik S; Parchi P; Giaccone G; Collins SJ; Kofskey D; Wang H; McLean CA; Brandel JP; Privat N; Sazdovitch V; Duyckaerts C; Kitamoto T; Belay ED; Maddox RA; Tagliavini F; Pocchiari M; Leschek E; Appleby BS; Safar JG; Schonberger LB; Gambetti P
Acta Neuropathol Commun; 2018 Jan; 6(1):5. PubMed ID: 29310723
[TBL] [Abstract][Full Text] [Related]
5. Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition.
Iwasaki Y; Imamura K; Iwai K; Kobayashi Y; Akagi A; Mimuro M; Miyahara H; Kitamoto T; Yoshida M
Neuropathology; 2018 Oct; 38(5):549-556. PubMed ID: 30084170
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.
Hainfellner JA; Wanschitz J; Jellinger K; Liberski PP; Gullotta F; Budka H
Acta Neuropathol; 1998 Aug; 96(2):116-22. PubMed ID: 9705125
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting.
Shimizu S; Hoshi K; Muramoto T; Homma M; Ironside JW; Kuzuhara S; Sato T; Yamamoto T; Kitamoto T
Arch Neurol; 1999 Mar; 56(3):357-62. PubMed ID: 10190828
[TBL] [Abstract][Full Text] [Related]
8. [Creutzfeldt-Jakob disease in a dura transplant recipient: first observation in Austria].
Radbauer C; Hainfellner JA; Gaudernak T; Deecke L; Budka H
Wien Klin Wochenschr; 1998 Jul; 110(13-14):496-500. PubMed ID: 9746964
[TBL] [Abstract][Full Text] [Related]
9. Atypical form of dural graft associated Creutzfeldt-Jakob disease: report of a postmortem case with review of the literature.
Kimura K; Nonaka A; Tashiro H; Yaginuma M; Shimokawa R; Okeda R; Yamada M
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):696-9. PubMed ID: 11309472
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
Iwasaki Y; Mimuro M; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
Neuropathology; 2008 Feb; 28(1):51-61. PubMed ID: 18181835
[TBL] [Abstract][Full Text] [Related]
11. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
[TBL] [Abstract][Full Text] [Related]
14. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
Ritchie DL; Adlard P; Peden AH; Lowrie S; Le Grice M; Burns K; Jackson RJ; Yull H; Keogh MJ; Wei W; Chinnery PF; Head MW; Ironside JW
Acta Neuropathol; 2017 Aug; 134(2):221-240. PubMed ID: 28349199
[TBL] [Abstract][Full Text] [Related]
16. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
Jaunmuktane Z; Mead S; Ellis M; Wadsworth JD; Nicoll AJ; Kenny J; Launchbury F; Linehan J; Richard-Loendt A; Walker AS; Rudge P; Collinge J; Brandner S
Nature; 2015 Sep; 525(7568):247-50. PubMed ID: 26354483
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
[TBL] [Abstract][Full Text] [Related]
18. Creutzfeldt-Jakob disease with florid plaques after cadaveric dura mater graft.
Mochizuki Y; Mizutani T; Tajiri N; Oinuma T; Nemoto N; Kakimi S; Kitamoto T
Neuropathology; 2003 Jun; 23(2):136-40. PubMed ID: 12777102
[TBL] [Abstract][Full Text] [Related]
19. Dura mater graft-associated Creutzfeldt-Jakob disease with 30-year incubation period.
Shijo M; Honda H; Koyama S; Ishitsuka K; Maeda K; Kuroda J; Tanii M; Kitazono T; Iwaki T
Neuropathology; 2017 Jun; 37(3):275-281. PubMed ID: 27925304
[TBL] [Abstract][Full Text] [Related]
20. Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?
Kovacs GG
Prion; 2016 Sep; 10(5):369-376. PubMed ID: 27649940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
